%20(2).png)
.png)
The Ongoing Global Burden of PRRSV
PRRSV remains one of the most economically damaging infectious diseases affecting the global swine industry, contributing to billions in annual losses through respiratory disease, reproductive failure, mortality, reduced growth performance, and increased production costs.
Economic Impact
PRRSV is estimated to cost the global pork industry more than $2 billion annually through decreased productivity, treatment costs, and herd instability.
Rapid Viral Evolution
The continuous mutation and co-circulation of both Type 1 and Type 2 PRRSV strains create major challenges for long-term disease control and vaccine efficacy.
High Production Losses
Outbreaks can result in:
-
Increased piglet mortality
-
Severe respiratory disease
-
Reproductive failure in breeding herds
-
Reduced average daily gain
-
Elevated veterinary intervention costs
Cross-Strain Vulnerability
Conventional monovalent vaccines often provide limited cross-protection against genetically diverse or emerging PRRSV strains, leaving herds vulnerable to reinfection and production disruption.
Advancing Through Controlled Challenge Studies
Current development activities are focused on generating a comprehensive efficacy and safety data package through controlled live pig challenge studies designed to support future regulatory submissions and global licensing discussions.
Safety Evaluation
Assessment parameters include:
-
Reduction in viremia
-
Reduced viral shedding
-
Local tolerance assessment
-
Monitoring for adverse clinical responses
-
Evaluation of overall production performance
Efficacy Evaluation
Challenge studies are designed to demonstrate:
-
Reduced respiratory disease severity
-
Lower lung lesion scores
-
Reduced rectal temperature elevation
-
Lower viral load following heterologous challenge
-
Broader protection across genetically diverse strains
Tailored Vaccine Capability
Additional studies are evaluating the platform’s ability to be adapted toward regionally relevant and emerging PRRSV lineages, including highly pathogenic variants circulating in Asia.
What our customers are saying
This is the space to share a review from one of the business's clients or customers.
Customer's name
This is the space to share a review from one of the business's clients or customers.
Customer's name
This is the space to share a review from one of the business's clients or customers.
Customer's name
Describe the team member here.
Team Member #1
Role description
Team Member #2
Role description
Team Member #3
Role description
Team Member #4
Role description
Team Member #5
Role description
Team Member #6
Role description